Pharma Business Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pharma Business Week


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Angiotech Pharmaceuticals

News published by Angiotech Pharmaceuticals officials updates activities

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Angiotech Pharmaceuticals.

Report 1: Angiotech Pharmaceuticals, Inc. (ANPI, ANP) announced that they received a favorable decision from a Dutch Court in a patent dispute against Conor Medsystems, Inc.

The District Court in The Hague held that Conor's CoStar paclitaxel stent infringes a key claim of the Dutch version of an important Angiotech European stent patent, and that Conor is therefore immediately enjoined from selling CoStar in the Netherlands.

...

• View Other Issues of Pharma Business Week
  
• View Other NewsRx Publications